等待开盘 04-18 09:30:00 美东时间
+0.230
+0.80%
坎托菲茨杰拉德公司:重申Agios Pharmaceuticals(AGIO.US)增持评级。
04-09 20:31
Cantor Fitzgerald analyst Eric Schmidt reiterates Agios Pharmaceuticals (NASDAQ:AGIO) with a Overweight.
04-09 20:27
Agios Pharmaceuticals (NASDAQ:AGIO) reported quarterly sales of $7.10 million which missed the analyst consensus estimate of $7.94 million by 10.58 percent. This is a 64.73 percent increase over sales of $4.31 million
02-15 20:03
Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on revenue of $188.59 million.
02-15 18:17
Agios Pharmaceuticals (NASDAQ:AGIO) is set to give its latest quarterly earning...
02-15 01:01
生物科技投资者看好小盘股,对中盘股的乐观情绪也逐渐升温,并认为Fusion和Merus最有可能在今年跑赢大盘。
02-05 07:37
隔夜,美股三大指数均收涨,道指涨0.64%,纳指涨0.18%,标普500指数涨0.53%再创新高。美股创新药板块,纳斯达克生物科技指数(NBI)反弹,收涨0....
01-26 11:45
Agios Pharmaceuticals Inc (NASDAQ: AGIO) says the Phase 3 ENERGIZE study of mitapivat in adults with non-transfusion-dependent (NTD) alpha- or beta-thalassemia achieved its primary
01-03 22:45
AGIO: 22% | Agios Pharmaceuticals shares are trading higher after the company announced its Phase 3 ENERGIZE study of Mitapivat met its primary and both key secondary endpoints. SOFI: -5% | SoFi
01-03 21:36
Market forces rained on the parade of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)...
2023-11-09 06:14